News:Research and scientific results

A clinical trial conducted jointly by the Research Institute of Hospital del Mar and the Barcelonaβeta Brain Research Center, concludes that combining a healthy lifestyle program with epigallocatechin gallate (EGCG), a natural compound found in green tea, could offer sustained cognitive benefits in people at high risk of developing Alzheimer’s dise

This research achieved a more precise measurement of sleep quality thanks to the combined use of actigraphy, brain MRI scans, and biomarker analysis.

The international consortium has analyzed almost 40,000 biological samples to identify biomarkers in Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases.

This study suggests that certain stressful life events can impact brain health differently depending on gender and educational level

This fully automated blood test could become a scalable, minimally invasive tool to detect and monitor Alzheimer’s-related changes long before symptoms appear.

The study, published in the journal Alzheimer’s & Dementia, involved 337 people from the ALFA longitudinal cohort of the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation.

A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.

The study highlights the need to adapt recruitment strategies to existing gender differences to ensure equitable representation in research.

The findings revealed that plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer’s compared to other biomarkers